SpeechPathology.com Phone: 800-242-5183


EDU Healthcare Opportunities

When to Recommend Therapy for Parkinson's Disease

Jessica Huber, Ph.D., CCC-SLP

May 5, 2014

Share:

Question

I have a client with Parkinson’s Disease who I just evaluated. He is on Medicare so each visit is crucial and limited.  He exhibits a slight voice warble with sustained production of the /z/ phoneme, and I did not recommend therapy at this time.  Any thoughts?

Answer

I always think about therapy candidacy from the perspective of how the patient is functioning in everyday life.  If they are not noticing that their speech is changing, they are not saying, for example, that they are withdrawing from social situations, or they do not feel that their daily life is impacted, and when you listen to them, you and the patient's family are not hearing big changes, it is okay to not recommend therapy.  You want to save therapy, especially with Medicare where visits are so highly controlled, for people who are really having significant problems and who are reporting changes to their everyday life.  I think you made a great decision about therapy efficacy and who should be getting therapy.  

Jessica Huber Ph.D., CCC-SLP, is an Associate Professor at Purdue University in the Speech, Language, and Hearing Sciences Department. Her research emphasis is on the effects of aging and motor disorders on speech production. Her current research focus is the treatment speech, balance, and cognitive changes as a result of Parkinson's disease and aging.


jessica huber

Jessica Huber, Ph.D., CCC-SLP

Jessica Huber Ph.D., CCC-SLP, is an Associate Professor at Purdue University in the Speech, Language, and Hearing Sciences Department. Her research emphasis is on the effects of aging and motor disorders on speech production. Her current research focus is the treatment of speech, balance, and cognitive changes as a result of Parkinson's disease and aging.


Related Courses

Behavioral Frameworks for Dementia Management
Presented by Mary Beth Mason, PhD, CCC-SLP, Robert W. Serianni, MS, CCC-SLP, FNAP
Video

Presenters

Mary Beth Mason, PhD, CCC-SLPRobert W. Serianni, MS, CCC-SLP, FNAP
Course: #9473Level: Intermediate1 Hour
  'Straightforward with clinically applicable information'   Read Reviews
This course will focus on cognitive-communication intervention strategies for various dementia presentations and will provide a review of evidence-based treatment. Behavioral frameworks along with their rationales will be introduced and applied across several dementia types and mild, moderate and severe levels of impairment.

Dysphagia in Neurodegenerative Disease
Presented by Debra M. Suiter, PhD, CCC-SLP, BCS-S
Video

Presenter

Debra M. Suiter, PhD, CCC-SLP, BCS-S
Course: #9732Level: Intermediate1 Hour
  'The information presented was clinically specific and objective for assessing and helping patients make decisions around their dysphagia in these NDD's'   Read Reviews
Dysphagia is common in individuals with amyotrophic lateral sclerosis (ALS) and Parkinson’s disease. This course discusses the underlying pathophysiology and appropriate treatment programs for each disease, as well as use of alternate methods of nutrition/hydration.

20Q: Induced Laryngeal Obstruction - An Overview for Speech-Language Pathologists
Presented by Robert Brinton Fujiki, PhD, CCC-SLP
Text

Presenter

Robert Brinton Fujiki, PhD, CCC-SLP
Course: #10761Level: Intermediate1 Hour
  'The breakdown of a general introduction to ILO was a great refresher! I also appreciated the more specific topics such as examples of treatment techniques as the course continued'   Read Reviews
The nature of induced laryngeal obstruction, including comorbidities and causes, and the speech-language pathologist’s role in evaluation and treatment of this disorder are described in this course. Current diagnostic and treatment practices and research updates pertaining to the condition are discussed.

20Q: Evaluation and Treatment of Speech/Resonance Disorders and Velopharyngeal Dysfunction
Presented by Ann W. Kummer, PhD, CCC-SLP
Text

Presenter

Ann W. Kummer, PhD, CCC-SLP
Course: #8729Level: Intermediate1 Hour
  'I am currently working with a 31 year old woman who has MS and hypernasality and decreased speech intelligibility'   Read Reviews
Children with speech and resonance disorders (hypernasality, hyponasality, and cul-de-sac resonance) and/or nasal emission present challenges for speech-language pathologists (SLPs) in all settings. This article will help participants to recognize resonance disorders and the characteristics of velopharyngeal dysfunction, and provide appropriate management.

Best Practice for Assessment and Treatment of Bilingual Aphasia
Presented by Maria Muñoz, PhD, CCC-SLP
Video

Presenter

Maria Muñoz, PhD, CCC-SLP
Course: #9759Level: Intermediate1.5 Hours
  'I like the way the course explained multiple patterns of recovery and that it provided a greater understanding of premorbid bilingualism'   Read Reviews
This course focuses on best practice in the assessment and treatment of bilingual aphasia by speech-language pathologists. Recommended practices are contrasted against common mistakes made by clinicians working with bilingual patients with aphasia. Implementation of best practices are modeled through case studies.

Our site uses cookies to improve your experience. By using our site, you agree to our Privacy Policy.